A tiny ILUVIEN microimplant is administered by your eye doctor during a brief in-office procedure so you won’t have to miss a moment of the things you truly love.
A tiny ILUVIEN microimplant is administered by your eye doctor during a brief in-office procedure so you won’t have to miss a moment of the things you truly love.
Prior to injection, your eye will be numbed. The ILUVIEN microimplant is then injected with a specialized inserter. As the microimplant is being injected, you may feel some pressure and possibly some discomfort afterward. This is generally normal and temporary. Talk with your eye doctor if you have questions about side effects.
People who receive injections in the eye can sometimes feel slight pressure in the eye afterward. This is generally normal and temporary. Talk with your eye doctor if you have questions about side effects.
Intravitreal injections, including those with ILUVIEN, have been associated with serious eye infection, eye inflammation, increased eye pressure, retinal detachments, glaucoma, cataracts, and implant migration. Your eye doctor will monitor your progress following the procedure.
Tell your eye doctor immediately if your eye becomes red, sensitive to light, painful, or develops a change in vision. Your eye doctor will want to see you on a regular basis.
It is important to keep your routine exams with your eye doctor. Committing to your eye health with ILUVIEN means keeping your appointments with your doctor.
For additional safety information, please talk to your eye doctor and see the ILUVIEN full Prescribing Information.
The number of treatments you receive will depend on your condition and on what your eye doctor thinks is best for you.
ILUVIEN is designed to release a continuous, low dose treatment to the retina for up to 36 months.
Your eye doctor will still want to see you periodically to monitor your condition and watch for the development of cataracts, eye infection (endophthalmitis), eye inflammation, increased eye pressure, glaucoma, and retinal detachments. It is important to keep your routine exams with your eye doctor.
INDICATION AND IMPORTANT SAFETY INFORMATION
ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.
ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Learn about the benefits of ILUVIEN, inspiring patient stories, financial assistance and more. We will keep emails to a minimum and only send you relevant, useful information!